Vergleich

Cytokeratin [MNF116]

ArtNr 20-272-192077
Hersteller GENWAY
Menge 0.5 ml
Kategorie
Typ Antibody
Applikationen IHC
Clon MNF116
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-3835D9
Similar products 20-272-192077
Lieferbar
Genway ID:
GWB-3835D9
Clone:
MNF116
Isotype:
IgG1Light chain: kappa
Immunogen:
Crude extract of splenic cells from a nude mouse engrafted with MCF-7 cells.
Antigen Species:
Human
Specificity:
Recognizes keratin polypeptide of 45 46 and 56. 5 kDa. Shows a broad pattern of reactivity with human epithelial tissues from simple glandular epithelia to stratified squamous epithelia like epidermis mammary gland ducts and tracheal epithelium.
Positive Control:
Skin
Target:
Cytokeratin
Concentration:
Tissue culture supernatant Storage
Buffer:
Tissue culture supernatant containing sodium azide
Application Note:
For IHC-P: Use at a dilution of 1:25-1:50 in an ABC method. Suggested incubation period of 30mins at RT. Enzymatic predigestion of paraffin embedded tissues is recommended prior to the immunostaining. Not tested in other applications. Optimal dilutions/concentrations should be determined by the researcher. Cytokeratins a group of at least 29 different proteins are characteristic of epithelial and trichocytic cells. Cytokeratins 4 5 6 and 8 are members of the type II neutral-to-basic subfamily. Cytokeratin peptide 4 (59 kDa) is the secondary type II keratin expressed in non cornified stratified squamous epithelia. Cytokeratin peptide 5 (58 kDa) is the primary type II keratin in stratified epithelia while cytokeratin type 8 (52 kDa) is a major type II keratin in simple epithelia. Cytokeratin 6 (56 kDa) is a \" hyperproliferation\" cytokeratin expressed in tissues with natural or pathological high turnover. Cytokeratins 10 13 and 18 are members of the type I acidic subfamily. Cytokeratin peptide 10 (56 kDa) is the secondary type I keratin expressed in cornified epithelia. Cytokeratin 13 (54 kDa) is the secondary type I keratin expressed in non-cornified stratified squamous epithelia. Cytokeratin 18 (45 kDa) is the primary type I keratin expressed in simple epithelial cells. Cytokeratin is a heterotetramer of two type I and two type II keratins. Keratin 1 is generally associated with keratin 10. Defects in Cytokeratin are a cause of epidermolytic hyperkeratosis also known as bullous congenital ichthyosiform erythroderma (BIE) which is a hereditary skin disorder characterized by blistering and a marked thickening of the stratum corneum. Defects in Cytokeratin are also the cause of Curth Macklin type ichthyosis hystrix nonepidermolytic palmoplantar keratoderma annular epidermolytic ichthyosis and keratosis palmoplantaris striata III (PPKS3). PPKS3 is an autosomal dominant disorder affecting palm and sole skin where stratum corneum and epidermal layers are thickened. There is no involvement of nonpalmoplantar skin and both hair and nails are normal.
Function:
May regulate the activity of kinases such as PKC and SRC via binding to integrin beta-1 (ITB1) and the receptor of activated protein kinase C (RACK1/GNB2L1).
Subunit:
Heterotetramer of two type I and two type II keratins. Keratin-1 is generally associated with keratin-10. Interacts with ITGB1 in the presence of GNB2L1 and SRC and with GNB2L1.
Subcellular Location:
Cell membrane. Note=Located on plasma membrane of neuroblastoma NMB7 cells.
Tissue Specificity:
The source of this protein is neonatal foreskin. The 67-kDa type II keratins are expressed in terminally differentiating epidermis.
Ptm:
Undergoes deimination of some arginine residues (citrullination).
Polymorphism:
There are two size variants of KRT1 termed allele 1A and allele 1B with allelic frequencies of 0. 61 and 0. 39. Allele 1B lacks 7 residues compared to allele 1A.
Disease:
Defects in KRT1 are a cause of bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800]; also known as epidermolytic hyperkeratosis (EHK) or bullous erythroderma ichthyosiformis congenita of Brocq. BCIE is an autosomal dominant skin disorder characterized by widespread blistering and an ichthyotic erythroderma at birth that persist into adulthood. Histologically there is a diffuse epidermolytic degeneration in the lower spinous layer of the epidermis. Within a few weeks from birth erythroderma and blister formation diminish and hyperkeratoses develop.
Disease:
Defects in KRT1 are the cause of ichthyosis hystrix Curth-Macklin type (IHCM) [MIM:146590]. IHCM is a genodermatosis with severe verrucous hyperkeratosis. Affected individuals manifest congenital verrucous black scale on the scalp neck and limbs with truncal erythema palmoplantar keratoderma and keratoses on the lips ears nipples and buttocks.
Disease:
Defects in KRT1 are a cause of palmoplantar keratoderma non-epidermolytic (NEPPK) [MIM:600962]. NEPKK is a dermatological disorder characterized by focal palmoplantar keratoderma with oral genital and follicular lesions.
Disease:
Defects in KRT1 are a cause of ichthyosis annular epidermolytic (AEI) [MIM:607602]; also known as cyclic ichthyosis with epidermolytic hyperkeratosis. AEI is a skin disorder resembling bullous congenital ichthyosiform erythroderma. Affected individuals present with bullous ichthyosis in early childhood and hyperkeratotic lichenified plaques in the flexural areas and extensor surfaces at later ages. The feature that distinguishes AEI from BCIE is dramatic episodes of flares of annular polycyclic plaques with scale which coalesce to involve most of the body surface and can persist for several weeks or even months.
Disease:
Defects in KRT1 are the cause of palmoplantar keratoderma striate type 3 (SPPK3) [MIM:607654]; also known as keratosis palmoplantaris striata III. SPPK3 is a dermatological disorder affecting palm and sole skin where stratum corneum and epidermal layers are thickened. There is no involvement of non-palmoplantar skin and both hair and nails are normal.
Miscellaneous:
There are two types of cytoskeletal and microfibrillar keratin: I (acidic; 40-55 kDa) and II (neutral to basic; 56-70 kDa).
Similarity:
Belongs to the intermediate filament family.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 0.5 ml
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen